Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

Annals of Internal Medicine, 05/25/2012

This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the prostate–specific antigen (PSA) test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the Update of the 2008 U.S. Preventive Services Task Force.

Print Article Summary Cat 2 CME Report